Table 1.

Clinicopathologic parameters of 33 samples from HMU

No.	Age range	Pathology (WHO)	No.	Age range	Pathology (WHO)
01	60–69	Brain Tissue	17	20–29	Pleomorphic Xanthoastrocytoma II
02	50–59	Brain Tissue	18	30–39	Diffuse Astrocytoma II
03	70–79	Brain Tissue	19	40–49	Anaplastic Oligoastrocytoma III
04	50–59	Brain Tissue	20	20–29	Anaplastic Astrocytoma III
05	60–69	Astrocytoma I	21	40–49	Anaplastic Oligoastrocytoma III
06	30–39	Astrocytoma I	22	50–59	Anaplastic Astrocytoma III
07	30–39	Astrocytoma I	23	50–59	Anaplastic Astrocytoma III
08	60–69	Astrocytoma I	24	20–29	Glioblastoma IV
09	40–49	Astrocytoma I	25	50–59	Glioblastoma IV
10	70–79	Oligoastrocytoma II	26	40–49	Glioblastoma IV
11	30–39	Oligoastrocytoma II	27	50–59	Glioblastoma IV
12	40–49	Astrocytoma II	28	40–49	Glioblastoma IV
13	40–49	Diffuse Astrocytoma II	29	30–39	Glioblastoma IV
14	30–39	Diffuse Astrocytoma II	30	50–59	Glioblastoma IV
15	60–69	Diffuse Astrocytoma II	31	70–79	Glioblastoma IV
16	40–49	Oligodendroglioma II	32	60–69	Glioblastoma IV
33	40–49	Glioblastoma IV

Abbreviation: WHO World Health Organization, HMU Harbin Medical University